Ranking · Unmet Need
Research Gap Index
Burden percentile minus research-activity percentile (publications, last 5 years) within the same scope. Positive values flag cancers with high mortality burden but comparatively little literature. Caveat (Phase 1): literature counts are query-based per entity (query stored on each row); they are not aggregated over descendants.
Computedci-research-gap-v1unit: percentile pointshigher = worseAll metrics
| Rank | Δ | Cancer | Research Gap Index (percentile points) | Percentile | Confidence | Sources | Why #n? |
|---|---|---|---|---|---|---|---|
| 1 | = | Malignant Central Nervous System Neoplasm | +70 | 100 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602889 |
| 2 | = | Malignant Uterine Corpus Neoplasm | +43.3 | 96.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602890 |
| 3 | = | Malignant Kidney Neoplasm | +20 | 93.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602892 |
| 3 | ▲1 | Malignant Pancreatic Neoplasm | +20 | 93.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602891 |
| 5 | = | Malignant Colon Neoplasm | +16.7 | 86.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602893 |
| 6 | = | Malignant Liver Neoplasm | +16.6 | 83.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602894 |
| 7 | = | Malignant Esophageal Neoplasm | +13.4 | 80 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602895 |
| 7 | = | Non-Hodgkin Lymphoma | +13.4 | 80 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602896 |
| 9 | = | Malignant Vulvar Neoplasm | +10 | 73.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602897 |
| 10 | ▲1 | Multiple Myeloma | +6.7 | 70 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602898 |
| 11 | ▼1 | Malignant Salivary Gland Neoplasm | +6.7 | 66.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602899 |
| 12 | = | Malignant Laryngeal Neoplasm | +3.4 | 63.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602900 |
| 13 | = | Malignant Lung Neoplasm | +3.3 | 60 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602901 |
| 14 | = | Cutaneous Melanoma | 0 | 56.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602902 |
| 14 | ▲1 | Malignant Bladder Neoplasm | 0 | 56.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602903 |
| 16 | ▼1 | Malignant Hypopharyngeal Neoplasm | -3.3 | 50 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602904 |
| 17 | ▲4 | Malignant Anal Neoplasm | -3.4 | 46.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602905 |
| 18 | ▼3 | Malignant Vaginal Neoplasm | -3.4 | 43.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602906 |
| 19 | ▼4 | Malignant Mesothelioma | -3.4 | 40 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602907 |
| 20 | ▲5 | Malignant Prostate Neoplasm | -6.6 | 36.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602908 |
| 21 | ▲3 | Malignant Nasopharyngeal Neoplasm | -6.7 | 33.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602909 |
| 22 | = | Leukemia | -6.7 | 30 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602910 |
| 22 | ▲3 | Malignant Breast Neoplasm | -6.7 | 30 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602911 |
| 22 | ▲5 | Malignant Rectal Neoplasm | -6.7 | 30 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602912 |
| 25 | ▲4 | Hodgkin Lymphoma | -20 | 20 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602913 |
| 25 | ▲6 | Malignant Ovarian Neoplasm | -20 | 20 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602914 |
| 27 | ▲5 | Malignant Penile Neoplasm | -23.3 | 13.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602915 |
| 27 | ▲5 | Malignant Testicular Neoplasm | -23.3 | 13.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602916 |
| 29 | ▲6 | Malignant Thyroid Gland Neoplasm | -30 | 6.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602917 |
| 30 | ▲4 | Malignant Gastric Neoplasm | -36.7 | 3.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602918 |
| 31 | ▲5 | Malignant Cervical Neoplasm | -43.3 | 0 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2602919 |
Data updated 16 hours agoSource updated unknown31 eligible entities · inputs hash 97630aee02baec61fd34d642